JGC
EIGR

J. Goldman & Co’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

J. Goldman & Co’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,002
Closed -$2.86M – 296
2020
Q1 		$2.86M Buy
14,002
+12,486
+824% +$2.55M 0.34% 56
2019
Q4 		$677K Buy
+1,516
New +$677K 0.05% 133